Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Trial of Aeroquin Versus Tobramycin Inhalation Solution (TIS) in Cystic Fibrosis (CF) Patients

ClinicalTrials.gov ID: NCT01270347

Public ClinicalTrials.gov record NCT01270347. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 9:51 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Phase 3, Open-label, Randomized Trial to Evaluate the Safety and Efficacy of MP-376 Inhalation Solution (Aeroquin) vs. Tobramycin Inhalation Solution (TIS) in Stable CF Patients

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Patients with cystic fibrosis (CF) suffer from chronic infections of the lower respiratory tract that can be caused by one or multiple bacteria, including Pseudomonas aeruginosa, which has been particularly problematic to eradicate and been implicated as the major cause of morbidity and mortality in CF patients. Aerosol delivery of antibiotics directly to the lung increases the local concentrations of antibiotic at the site of infection resulting in improved antimicrobial effects compared to systemic administration. Bacterial resistance to current aerosol antibiotic treatments indicate a need for improved therapies to treat CF patients with pulmonary infections caused by multi-drug resistant Pseudomonas aeruginosa and other bacteria. High concentrations of MP-376 delivered directly to the lung are projected to have antimicrobial effects on even the most resistant organisms.

Study identification

NCT ID
NCT01270347
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Amgen
Industry
Enrollment
282 participants

Conditions and interventions

Eligibility (public fields only)

Age range
12 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 2011 (Type not available)
Primary completion
Oct 2012 (Actual)
Completion
Jun 2013 (Actual)
Last update posted
Dec 13, 2024

2011 – 2013

United States locations

U.S. sites
99
U.S. states
42
U.S. cities
89
Facility City State ZIP Site status
Not listed Mobile Alabama 36608 —
Not listed Anchorage Alaska 99508 —
Not listed Phoenix Arizona 85016 —
Not listed Tucson Arizona 85724 —
Not listed Little Rock Arkansas 72202 —
Not listed La Jolla California 92037 —
Not listed Long Beach California 90806 —
Childrens Hospital Los Angeles California 90027 —
Not listed Los Angeles California 90033 —
Not listed Oakland California 94611 —
Not listed Orange California 92868 —
Not listed Palo Alto California 94304 —
Not listed Sacramento California 95817 —
Not listed San Diego California 92103 —
Not listed San Diego California 92123 —
Not listed San Francisco California 94115 —
Not listed Aurora Colorado 80045 —
Not listed Denver Colorado 80206 —
Not listed Hartford Connecticut 06106 —
Not listed New Haven Connecticut 65020 —
Not listed Wilmington Delaware 19803 —
Not listed Gainesville Florida 32610 —
Not listed Jacksonville Florida 32207 —
Not listed Miami Florida 33136 —
Not listed Orlando Florida 32801 —
Not listed St. Petersburg Florida 33701 —
Not listed Tampa Florida 33606 —
Not listed Atlanta Georgia 30322 —
Not listed Boise Idaho 83712 —
Not listed Chicago Illinois 60614 —
Not listed Chicago Illinois 60637 —
Not listed Glenview Illinois 60025 —
Not listed Niles Illinois 60714 —
Not listed Peoria Illinois 61637 —
Not listed Indianapolis Indiana 43202 —
Not listed Indianapolis Indiana 46202 —
Not listed Wichita Kansas 67214 —
Not listed Lexington Kentucky 40536 —
Not listed Louisville Kentucky 40202 —
Not listed Portland Maine 04102 —
Not listed Baltimore Maryland 21287 —
Not listed Boston Massachusetts 02114 —
Not listed Boston Massachusetts 02115 —
Not listed Worcester Massachusetts 01655 —
Not listed Ann Arbor Michigan 48109 —
Not listed Detroit Michigan 48201 —
Not listed Grand Rapids Michigan 49503 —
Not listed Minneapolis Minnesota 55455 —
Not listed Jackson Mississippi 39216 —
Not listed Columbia Missouri 65212 —
Not listed Kansas City Missouri 64108 —
Not listed St Louis Missouri 63110 —
Not listed Omaha Nebraska 68105 —
Not listed Las Vegas Nevada 89107 —
Not listed Lebanon New Hampshire 03756 —
Not listed Manchester New Hampshire 03104 —
Not listed Livingston New Jersey 07039 —
Not listed Morristown New Jersey 07962 —
Not listed Albuquerque New Mexico 87131 —
Albany Medical College #2 Albany New York 12208 —
Not listed Albany New York 12208 —
Not listed New Hyde Park New York 11042 —
Not listed New York New York 10003 —
Not listed New York New York 10032 —
Not listed Syracuse New York 13210 —
Not listed Valhalla New York 10595 —
Not listed Durham North Carolina 27710 —
Not listed Akron Ohio 44308 —
Not listed Cincinnati Ohio 45229 —
Not listed Columbus Ohio 43205 —
Not listed Dayton Ohio 45404 —
Not listed Toledo Ohio 43606 —
Oklahoma CF Center Oklahoma City Oklahoma 73104 —
Not listed Oklahoma City Oklahoma 73112 —
Not listed Hershey Pennsylvania 17033 —
Not listed Philadelphia Pennsylvania 19102 —
Not listed Philadelphia Pennsylvania 19104 —
Not listed Pittsburgh Pennsylvania 15224 —
Not listed Charleston South Carolina 29425 —
Not listed Columbia South Carolina 29203 —
Not listed Sioux Falls South Dakota 57117 —
Not listed Memphis Tennessee 38105 —
Not listed Nashville Tennessee 37232 —
Not listed Austin Texas 78723 —
Not listed Dallas Texas 75390 —
Not listed Fort Worth Texas 76104 —
Not listed Houston Texas 77030 —
Not listed San Antonio Texas 78212 —
Not listed Tyler Texas 75708 —
Not listed Salt Lake City Utah 84132 —
Not listed Colchester Vermont 05446 —
Not listed Charlottesville Virginia 22908 —
Not listed Norfolk Virginia 23507 —
Not listed Portsmouth Virginia 23708 —
Not listed Richmond Virginia 23298 —
Not listed Seattle Washington 98105 —
Not listed Morgantown West Virginia 26506 —
Not listed Milwaukee Wisconsin 53201 —
Not listed Milwaukee Wisconsin 53266 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 31 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01270347, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 13, 2024 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01270347 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →